Trametes Versicolor: Turkey Tail Mushrooms Help Immune System Fight Cancer

A promising clinical study shows that the turkey tail mushroom (Trametes versicolor) improves the immune systems of breast cancer patients. The multiyear study, funded by the National Institutes of Health (NIH), tracked whether or not turkey tails could positively affect the immune system of patients rebound after they ended their radiation therapy.

Immunity — as measured by the number of lymphocyte cells and natural killer cell activity — usually declines dramatically after radiotherapy. Natural killer (NK) cells protect us from tumors and viruses. Researchers at the University of Minnesota Medical School and Bastyr University Research Institute hypothesized that breast cancer patients’ health can be improved after radiation treatment if NK cell counts increased quickly to attack remaining cancerous cells.

The study titled “Phase I Clinical Trial of Trametes versicolor in Women with Breast Cancer,” recently published in the ISRN Oncology Journal, shows that turkey tail mushrooms can augment conventional therapies for treating breast cancer by increasing NK and CD8+T cell activity. This study suggests that turkey tail mushrooms are an effective adjunct to conventional chemotherapeutic medicines and radiation therapy. The authors concluded:

… research by our center continues to indicate that Trametes versicolor represents a novel immune therapy with significant applications in cancer treatment … The CD8+ T cell counts over the 9-week dose escalation study were enhanced in the 9 gm Tv dose cohort compared to both the 3 g or 6 g group. One-way ANOVA was used to analyze the overall difference between dosage groups over the treatment period (2-4-6 weeks). It showed the statistically significant increase in the CD8+ cytotoxic T cells for the 9 g group compared to both the 3 g and 6 g group (F(2, 6) = 42.04, P = 0.0003).

Due to its long history of therapeutic use, however, turkey tail prepared and packaged as an immune therapy drug is unlikely to be patentable, deterring big pharmas from conducting costly clinical studies. Typically, the longer the historical use of natural medicines for treating an ailment, the less likely derivatized drugs from these natural products will be patentable. To fill this research gap, the NIH established The National Center for Complementary and Alternative Medicine (www.nccam.nih.gov), which funded and oversaw this study. NIH’s interest is not surprising — more than 70 percent of new drugs are estimated to originate from natural sources.

Turkey tail mushrooms have been used to treat various maladies for hundreds of years in Asia, Europe, and by indigenous peoples in North America. Records of turkey tail brewed as medicinal tea date from the early 15th century, during the Ming Dynasty in China. Our ancestors certainly encountered them and most likely explored their uses long before written history. Since the late 1960s, researchers in Japan have focused on how turkey tail benefits human health and how extracts of turkey tail can boost the immune system.

What are turkey tail mushrooms?

This super-abundant colorful mushroom grows on dead trees, logs, branches, and stumps. Turkey tail mushrooms are called bracket fungi, meaning that they form thin, leather-like and leaf-like structures in concentric circles. Rather than gills underneath, as in shiitake mushrooms, their undersides have tiny pores, which emit spores, placing them in the polypore family. These mushrooms grow throughout the world, practically wherever trees can be found. In fact, turkey tails are some of most common mushrooms found on wood on the planet.

They are commonly called “turkey tail” because their various colors: brown, orange, maroon, blue and green — reminiscent of the plume of feathers in turkeys. In China, their common name is yun zhi. In Japan, this mushroom is known as kawaritake or “cloud mushrooms,” invoking an image of swirling clouds overhead. In many Asian cultures, turkey tails’ incurving cloud forms symbolize longevity and health, spiritual attunement and infinity.

What are the medicinal properties and how is it used?

Traditionally, our ancestors boiled mushrooms in water to make a soothing tea. Boiling served several purposes: killing contaminants, softening the flesh, and extracting the rich soluble polysaccharides. The mushrooms — called fruiting bodies by mycologists — are made of densely-compacted cobwebby cells called mycelium. With modern laboratory methods of cell tissue culture, the large-scale production of mycelium brought to light a whole new array of medicinal preparations. Nowadays, the commercial production of mycelium enables a cleaner and more digestible product than traditional mushroom preparations. Surprisingly, novel compounds are continually being discovered, which are not available using traditional preparations of the fruiting bodies, but are detectable within, and excreted from the rapidly growing mycelium.

The natural killer cells promoted by ingesting turkey tails also target virally-infected cells. Moreover, turkey tail mycelium excretes strong antiviral compounds, specifically active against Human papillomavirus (HPV), which causes cervical cancer, and hepatitis C virus (HEP-C), which causes liver cancer. Viruses that induce cancer are called “oncoviruses.” The virus-to-cancer connection is where medicinal mushrooms offer unique opportunities for medical research. The current thinking amongst many researchers is that turkey tails and other medicinal mushrooms lessen the odds of getting cancer by reducing causal co-factors such as oncoviruses.

Full Article

medicalschool:

Breast Cancer Cells

medicalschool:

Breast Cancer Cells

medicalschool:

National Museum of Health and Medicine : Washington, D.C.Assorted anatomical models; Drawer in backroom.

medicalschool:

National Museum of Health and Medicine : Washington, D.C.
Assorted anatomical models; Drawer in backroom.

medicalschool:

SEM of a single red blood cell on the tip of a needle

medicalschool:

SEM of a single red blood cell on the tip of a needle

ucsdhealthsciences:

Malcolm Has a Mini Stroke: three questions for Alexander Khalessi, director of Neurovascular Surgery
Last week, former childhood star Frankie Muniz suffered a “mini stroke.” The news was remarkable for several reasons as Muniz, who was the titular star of Malcolm In the Middle, is just 27 years old and seems to live a healthy lifestyle. According to Muniz, he has “… never had a sip of alcohol in my life. I’ve never had any drugs, I’ve never even smoked a cigarette.”
According to the Centers for Disease Control, stroke is the leading cause of death in the United States, attributing to over 800,000 deaths a year. The causes for stroke range from existing conditions such as high blood pressure, to adverse behaviors such as smoking and excessive drinking. But what if you don’t have these risk factors?
We’ve asked Alexander Khalessi, MD, MS, director of Neurovascular Surgery and surgical director for the NeuroCritical Care unit at UC San Diego Health System three questions about strokes.
Question: What is a mini stroke and how does it differ from other types of stroke?
Answer: “Mini strokes” usually refer to a Transient Ischemic Attack or TIA. These events involve a temporary lack of blood flow to part of the brain. Fortunately in these cases, blood flow to the brain is spontaneously restored without permanent damage. Symptoms vary based on the part of the brain involved and may include vision loss, weakness, numbness or speech difficulty. TIA’s carry an increased risk of future stroke and often signify plaque narrowing one of the four major arteries that provide blood flow to the brain. Sudden occurrence of these symptoms requires immediate medical attention.
Q: Frankie Muniz is 27 years old and, except for suffering a stroke, in good health. Does this mean that anyone can be at risk for stroke at any time?
A: Ischemic strokes are caused by a blockage of one of the major blood vessels supplying the brain, narrowing of the arteries of the brain itself, abnormal heart rhythms, or clotting disorders of the blood. Stroke risk increases with these known conditions or comorbidities including obesity, smoking, drug use, high blood pressure or diabetes. The incidence of stroke in young people has doubled in the last decade. In a young healthy person with Mr. Muniz’s presentation, a carotid dissection or traumatic tear in the wall of the carotid artery is likely the most common cause.
Q: After suffering a stroke, what can people do to limit their chance of reoccurrence?
A: After suffering a stroke, receiving a work-up at a center that diagnoses the cause of the stroke is critical to risk assessment and secondary prevention. Were an arterial blockage responsible, the patient’s stroke risk may remain high without open surgery (carotid endarterectomy) or treatment with catheters (carotid artery stenting). For strokes due to arrhythmias of the heart, blood thinning medications and heart rate control treatments may be required. Similarly, clotting disorders of the blood may require aggressive treatment. Stroke diagnosis represents only the first step in preventing a second event.
Image source: FanPop

ucsdhealthsciences:

Malcolm Has a Mini Stroke: three questions for Alexander Khalessi, director of Neurovascular Surgery

Last week, former childhood star Frankie Muniz suffered a “mini stroke.” The news was remarkable for several reasons as Muniz, who was the titular star of Malcolm In the Middle, is just 27 years old and seems to live a healthy lifestyle. According to Muniz, he has “… never had a sip of alcohol in my life. I’ve never had any drugs, I’ve never even smoked a cigarette.”

According to the Centers for Disease Control, stroke is the leading cause of death in the United States, attributing to over 800,000 deaths a year. The causes for stroke range from existing conditions such as high blood pressure, to adverse behaviors such as smoking and excessive drinking. But what if you don’t have these risk factors?

We’ve asked Alexander Khalessi, MD, MS, director of Neurovascular Surgery and surgical director for the NeuroCritical Care unit at UC San Diego Health System three questions about strokes.

Question: What is a mini stroke and how does it differ from other types of stroke?

Answer: “Mini strokes” usually refer to a Transient Ischemic Attack or TIA. These events involve a temporary lack of blood flow to part of the brain. Fortunately in these cases, blood flow to the brain is spontaneously restored without permanent damage. Symptoms vary based on the part of the brain involved and may include vision loss, weakness, numbness or speech difficulty. TIA’s carry an increased risk of future stroke and often signify plaque narrowing one of the four major arteries that provide blood flow to the brain. Sudden occurrence of these symptoms requires immediate medical attention.

Q: Frankie Muniz is 27 years old and, except for suffering a stroke, in good health. Does this mean that anyone can be at risk for stroke at any time?

A: Ischemic strokes are caused by a blockage of one of the major blood vessels supplying the brain, narrowing of the arteries of the brain itself, abnormal heart rhythms, or clotting disorders of the blood. Stroke risk increases with these known conditions or comorbidities including obesity, smoking, drug use, high blood pressure or diabetes. The incidence of stroke in young people has doubled in the last decade. In a young healthy person with Mr. Muniz’s presentation, a carotid dissection or traumatic tear in the wall of the carotid artery is likely the most common cause.

Q: After suffering a stroke, what can people do to limit their chance of reoccurrence?

A: After suffering a stroke, receiving a work-up at a center that diagnoses the cause of the stroke is critical to risk assessment and secondary prevention. Were an arterial blockage responsible, the patient’s stroke risk may remain high without open surgery (carotid endarterectomy) or treatment with catheters (carotid artery stenting). For strokes due to arrhythmias of the heart, blood thinning medications and heart rate control treatments may be required. Similarly, clotting disorders of the blood may require aggressive treatment. Stroke diagnosis represents only the first step in preventing a second event.

Image source: FanPop

Centella Asiatica


  Centella asiatica, commonly centella (Sinhala: ගොටුකොල, gotu kola in Sinhala, Mandukaparni in Sanskritमधुकपर्णी,Kannada (ಒಂದೆಲಗ). Tamil: வல்லாரை, vallarai  in Tamil, Kodakan in Malayalam(കൊടകന്‍)), is a small, herbaceous, annual plant of the family Mackinlayaceae or subfamily Mackinlayoideae of family Apiaceae, and is native to India, Sri Lanka, northern Australia, Indonesia, Iran, Malaysia, Melanesia, Papua New Guinea, and other parts of Asia. It is used as a medicinal herb in Ayurvedic medicine, traditional African medicine, and traditional Chinese medicine. Botanical synonyms include Hydrocotyle asiatica L. and Trisanthus cochinchinensis (Lour.).
  
  Centella is a mild adaptogen, is mildly antibacterial, antiviral, anti-inflammatory, antiulcerogenic, anxiolytic, nervine and vulnerary, and can act as a cerebral tonic, a circulatory stimulant, and a diuretic.
  
  Centella asiatica may be useful in the treatment of anxiety.
  
  In Thailand, tisanes of the leaves are used as an afternoon stimulant. A decoction of juice from the leaves is thought to relieve hypertension. A poultice of the leaves is also used to treat open sores.
  
  Richard Lucas claimed in a book published in 1966(second edition in 1979) that a subspecies “Hydrocotyle asiatica minor” allegedly from Sri Lanka also called fo ti tieng, contained a longevity factor called ‘youth Vitamin X’ said to be ‘a tonic for the brain and endocrine glands’ and maintained that extracts of the plant help circulation and skin problems. However according to medicinal herbalist Michael Moore, it appears that there is no such subspecies and no Vitamin X is known to exist.
  
  Several scientific reports have documented Centella asiatica’s ability to aid wound healing which is responsible for its traditional use in leprosy. Upon treatment with Centella asiatica, maturation of the scar is stimulated by the production of type I collagen. The treatment also results in a marked decrease in inflammatory reaction and myofibroblast production.
  
  The isolated steroids from the plant also have been used to treat leprosy. In addition, preliminary evidence suggests that it may have nootropic effects. Centella asiatica is used to revitalize the brain and nervous system, increase attention span and concentration, and combat aging. Centella asiatica also has antioxidant properties. It works for venous insufficiency. It is used in Thailand for opium detoxification.
  
  Followers of Sri Sri Thakur Anukulchandra, commonly known as Satsangees, all over the world take one or two fresh leaves with plenty of water in the morning after morning rituals. This is prescribed by Sri Sri Thakur himself.
  
  Many reports show the medicinal properties of C. asiatica extract in a wide range of disease conditions, such as diabetic microangiopathy, edema, venous hypertension, and venous insufficiency. The role of C. asiatica extract in the treatment of memory enhancement and other neurodegenerative disorders is also well documented. The first report concerning the antitumor property of C. asiatica extract was on its growth inhibitory effects on the development of solid and ascites tumors, which lead to increased life span of tumor-bearing mice. The authors also suggested the extract directly impeded the DNA synthesis. “In our study, C. asiatica extract showed an obvious dose dependent inhibition of cell proliferation in breast cancer cells.”
  
  The Effects of Gotu Kola on the Brain
  
  Traditionally, Gotu kola has been used as a brain tonic to support memory. It has been called a “brain food” and has been recommended for overstressed people, mood, to improve reflexes and to support feelings of calmness. Gotu kola has also been studied in humans and was found to have a positive influence on enhancing peripheral circulation.
  
  Scientific research into Gotu kola extracts and its effects on the brain really only began in earnest in the past decade. In 2002, Gotu kola water extracts were administered to rats, where it improved their cognitive function in terms of learning and memory in a standard shuttle box avoidance and step through test. Brain levels of malondialdehyde (MDA), an indicator of overall oxidative stress, was reduced, and brain levels of the endogenous antioxidant glutathione were increased.

Centella Asiatica

Centella asiatica, commonly centella (Sinhala: ගොටුකොල, gotu kola in Sinhala, Mandukaparni in Sanskritमधुकपर्णी,Kannada (ಒಂದೆಲಗ). Tamil: வல்லாரை, vallarai in Tamil, Kodakan in Malayalam(കൊടകന്‍)), is a small, herbaceous, annual plant of the family Mackinlayaceae or subfamily Mackinlayoideae of family Apiaceae, and is native to India, Sri Lanka, northern Australia, Indonesia, Iran, Malaysia, Melanesia, Papua New Guinea, and other parts of Asia. It is used as a medicinal herb in Ayurvedic medicine, traditional African medicine, and traditional Chinese medicine. Botanical synonyms include Hydrocotyle asiatica L. and Trisanthus cochinchinensis (Lour.).

Centella is a mild adaptogen, is mildly antibacterial, antiviral, anti-inflammatory, antiulcerogenic, anxiolytic, nervine and vulnerary, and can act as a cerebral tonic, a circulatory stimulant, and a diuretic.

Centella asiatica may be useful in the treatment of anxiety.

In Thailand, tisanes of the leaves are used as an afternoon stimulant. A decoction of juice from the leaves is thought to relieve hypertension. A poultice of the leaves is also used to treat open sores.

Richard Lucas claimed in a book published in 1966(second edition in 1979) that a subspecies “Hydrocotyle asiatica minor” allegedly from Sri Lanka also called fo ti tieng, contained a longevity factor called ‘youth Vitamin X’ said to be ‘a tonic for the brain and endocrine glands’ and maintained that extracts of the plant help circulation and skin problems. However according to medicinal herbalist Michael Moore, it appears that there is no such subspecies and no Vitamin X is known to exist.

Several scientific reports have documented Centella asiatica’s ability to aid wound healing which is responsible for its traditional use in leprosy. Upon treatment with Centella asiatica, maturation of the scar is stimulated by the production of type I collagen. The treatment also results in a marked decrease in inflammatory reaction and myofibroblast production.

The isolated steroids from the plant also have been used to treat leprosy. In addition, preliminary evidence suggests that it may have nootropic effects. Centella asiatica is used to revitalize the brain and nervous system, increase attention span and concentration, and combat aging. Centella asiatica also has antioxidant properties. It works for venous insufficiency. It is used in Thailand for opium detoxification.

Followers of Sri Sri Thakur Anukulchandra, commonly known as Satsangees, all over the world take one or two fresh leaves with plenty of water in the morning after morning rituals. This is prescribed by Sri Sri Thakur himself.

Many reports show the medicinal properties of C. asiatica extract in a wide range of disease conditions, such as diabetic microangiopathy, edema, venous hypertension, and venous insufficiency. The role of C. asiatica extract in the treatment of memory enhancement and other neurodegenerative disorders is also well documented. The first report concerning the antitumor property of C. asiatica extract was on its growth inhibitory effects on the development of solid and ascites tumors, which lead to increased life span of tumor-bearing mice. The authors also suggested the extract directly impeded the DNA synthesis. “In our study, C. asiatica extract showed an obvious dose dependent inhibition of cell proliferation in breast cancer cells.”

The Effects of Gotu Kola on the Brain

Traditionally, Gotu kola has been used as a brain tonic to support memory. It has been called a “brain food” and has been recommended for overstressed people, mood, to improve reflexes and to support feelings of calmness. Gotu kola has also been studied in humans and was found to have a positive influence on enhancing peripheral circulation.

Scientific research into Gotu kola extracts and its effects on the brain really only began in earnest in the past decade. In 2002, Gotu kola water extracts were administered to rats, where it improved their cognitive function in terms of learning and memory in a standard shuttle box avoidance and step through test. Brain levels of malondialdehyde (MDA), an indicator of overall oxidative stress, was reduced, and brain levels of the endogenous antioxidant glutathione were increased.

frontal-cortex:

Figure 2. Angiographie sélective de l’artère rénale gauche. Anévrisme à l’origine de l’artère segmentaire du pôle inférieur du rein gauche. Cette anévrisme présente un large collet et son diamètre est de 6 mm environ.
Figure 2. Left renal angiography showing an aneurysm at the segmental artery of the left kidney’s inferior pole. This aneurysm exhibits a large collar and a diameter of approximately 6 mm.
Marcos Kubrusly et al. Hématurie macroscopique révélatrice d’un anévrisme des artères intrarénales; Néphrologie & Thérapeutique Volume 6, Issue 1, February 2010, Pages 47–51

frontal-cortex:

Figure 2. Angiographie sélective de l’artère rénale gauche. Anévrisme à l’origine de l’artère segmentaire du pôle inférieur du rein gauche. Cette anévrisme présente un large collet et son diamètre est de 6 mm environ.

Figure 2. Left renal angiography showing an aneurysm at the segmental artery of the left kidney’s inferior pole. This aneurysm exhibits a large collar and a diameter of approximately 6 mm.

Marcos Kubrusly et al. Hématurie macroscopique révélatrice d’un anévrisme des artères intrarénales; Néphrologie & Thérapeutique Volume 6, Issue 1, February 2010, Pages 47–51

Reishi Mushroom


  The lingzhi mushroom or reishi mushroom (traditional Chinese: 靈芝; pinyin: língzhī; Japanese: reishi; Vietnamese: linh chi; literally: “supernatural mushroom”) encompasses several fungal species of the genus Ganoderma, and most commonly refers to the closely related species, Ganoderma lucidum and Ganoderma tsugae. G. lucidum enjoys special veneration in East Asia, where it has been used as a medicinal mushroom in traditional Chinese medicine for more than 2,000 years, making it one of the oldest mushrooms known to have been used medicinally. Lingzhi is listed in the American Herbal Pharmacopoeia and Therapeutic Compendium.
  
  Ganoderma lucidum produces a group of triterpenes, called ganoderic acids, which have a molecular structure similar to steroid hormones. It also contains other compounds often found in fungal materials, including polysaccharides (such as beta-glucan), coumarin, mannitol, and alkaloids.
  
  Research & Medicinal Use
  
  Lingzhi may possess anti-tumor, immunomodulatory and immunotherapeutic activities, supported by studies on polysaccharides, terpenes, and other bioactive compounds isolated from fruiting bodies and mycelia of this fungus (reviewed by R. R. Paterson and Lindequist et al.). It has also been found to inhibit platelet aggregation, and to lower blood pressure (via inhibition of angiotensin-converting enzyme), cholesterol, and blood sugar.
  
  Laboratory studies have shown anti-neoplastic effects of fungal extracts or isolated compounds against some types of cancer, including epithelial ovarian cancer.[46] In an animal model, Ganoderma has been reported to prevent cancer metastasis, with potency comparable to Lentinan from Shiitake mushrooms.
  
  The mechanisms by which Ganoderma lucidum may affect cancer are unknown and they may target different stages of cancer development: inhibition of angiogenesis (formation of new, tumor-induced blood vessels, created to supply nutrients to the tumor) mediated by cytokines, cytoxicity, inhibiting migration of the cancer cells and metastasis, and inducing and enhancing apoptosis of tumor cells. Nevertheless, Ganoderma lucidum extracts are already used in commercial pharmaceuticals such as MC-S for suppressing cancer cell proliferation and migration.
  
  Additional studies indicate that ganoderic acid has some protective effects against liver injury by viruses and other toxic agents in mice, suggesting a potential benefit of this compound in the treatment of liver diseases in humans, and Ganoderma-derived sterols inhibit lanosterol 14α-demethylase activity in the biosynthesis of cholesterol . Ganoderma lucidum compounds inhibit 5-alpha reductase activity in the biosynthesis of dihydrotestosterone.
  
  Besides effects on mammalian physiology, Ganoderma lucidum is reported to have anti-bacterial and anti-viral activities. Ganoderma lucidum is reported to exhibit direct anti-viral with the following viruses; HSV-1, HSV-2, influenza virus, vesicular stomatitis.
  
  Ganoderma lucidum mushrooms are reported to exhibit direct anti-microbial properties with the following organisms; Aspergillus niger, Bacillus cereus, Candida albicans, and Escherichia coli. Other benefits were studied such as the effect of lowering hypertension, cholesterol, and anti-inflammatory benefits through the ganoderic acid properties.
  
  Its genome, with about 12,600 genes on 13 chromosomes, was sequenced in 2012.

Reishi Mushroom

The lingzhi mushroom or reishi mushroom (traditional Chinese: 靈芝; pinyin: língzhī; Japanese: reishi; Vietnamese: linh chi; literally: “supernatural mushroom”) encompasses several fungal species of the genus Ganoderma, and most commonly refers to the closely related species, Ganoderma lucidum and Ganoderma tsugae. G. lucidum enjoys special veneration in East Asia, where it has been used as a medicinal mushroom in traditional Chinese medicine for more than 2,000 years, making it one of the oldest mushrooms known to have been used medicinally. Lingzhi is listed in the American Herbal Pharmacopoeia and Therapeutic Compendium.

Ganoderma lucidum produces a group of triterpenes, called ganoderic acids, which have a molecular structure similar to steroid hormones. It also contains other compounds often found in fungal materials, including polysaccharides (such as beta-glucan), coumarin, mannitol, and alkaloids.

Research & Medicinal Use

Lingzhi may possess anti-tumor, immunomodulatory and immunotherapeutic activities, supported by studies on polysaccharides, terpenes, and other bioactive compounds isolated from fruiting bodies and mycelia of this fungus (reviewed by R. R. Paterson and Lindequist et al.). It has also been found to inhibit platelet aggregation, and to lower blood pressure (via inhibition of angiotensin-converting enzyme), cholesterol, and blood sugar.

Laboratory studies have shown anti-neoplastic effects of fungal extracts or isolated compounds against some types of cancer, including epithelial ovarian cancer.[46] In an animal model, Ganoderma has been reported to prevent cancer metastasis, with potency comparable to Lentinan from Shiitake mushrooms.

The mechanisms by which Ganoderma lucidum may affect cancer are unknown and they may target different stages of cancer development: inhibition of angiogenesis (formation of new, tumor-induced blood vessels, created to supply nutrients to the tumor) mediated by cytokines, cytoxicity, inhibiting migration of the cancer cells and metastasis, and inducing and enhancing apoptosis of tumor cells. Nevertheless, Ganoderma lucidum extracts are already used in commercial pharmaceuticals such as MC-S for suppressing cancer cell proliferation and migration.

Additional studies indicate that ganoderic acid has some protective effects against liver injury by viruses and other toxic agents in mice, suggesting a potential benefit of this compound in the treatment of liver diseases in humans, and Ganoderma-derived sterols inhibit lanosterol 14α-demethylase activity in the biosynthesis of cholesterol . Ganoderma lucidum compounds inhibit 5-alpha reductase activity in the biosynthesis of dihydrotestosterone.

Besides effects on mammalian physiology, Ganoderma lucidum is reported to have anti-bacterial and anti-viral activities. Ganoderma lucidum is reported to exhibit direct anti-viral with the following viruses; HSV-1, HSV-2, influenza virus, vesicular stomatitis.

Ganoderma lucidum mushrooms are reported to exhibit direct anti-microbial properties with the following organisms; Aspergillus niger, Bacillus cereus, Candida albicans, and Escherichia coli. Other benefits were studied such as the effect of lowering hypertension, cholesterol, and anti-inflammatory benefits through the ganoderic acid properties.

Its genome, with about 12,600 genes on 13 chromosomes, was sequenced in 2012.

I’ve been wanting to create an herbalism blog strictly sticking to the scientifically accurate side of herb life and medicine. But then Idk it sounds corny a little, I’m undecided. I mean I’ve seen a lot of pharma blogs and traditional medicine ones. but I’d like to see some quality content on the science of herbal medicine in general, the entire spectrum of medicinal herbs showing both physiological and psychological benefits, basically an herbalism blog that’s not just about cannabis and lulz420b*tch. What say you? Yay-yay or nay-nay? I’d obviously need some volunteers to join and help with the content. If anyone’s interested shoot me a message if not; I’ll scrape the idea.

scinerds:

nationalpost:

After having jaw, teeth, tongue and nerve tissue replaced, face transplant recipient regains speechFifteen years ago, Richard Lee Norris was shot in the face in a gun accident. He lost his nose, lips and most of the movement in his mouth.He was horribly disfigured, and he spent most of the next decade and a half in hiding, venturing out only occasionally at night in a cap and a surgical mask.Today, after receiving the most comprehensive face transplant to date, he says he’s able to walk past people without a second look. (University of Maryland Medical Center / Getty images)

Ahh, the wonders of science.

scinerds:

nationalpost:

After having jaw, teeth, tongue and nerve tissue replaced, face transplant recipient regains speech
Fifteen years ago, Richard Lee Norris was shot in the face in a gun accident. He lost his nose, lips and most of the movement in his mouth.

He was horribly disfigured, and he spent most of the next decade and a half in hiding, venturing out only occasionally at night in a cap and a surgical mask.

Today, after receiving the most comprehensive face transplant to date, he says he’s able to walk past people without a second look. (University of Maryland Medical Center / Getty images)


Ahh, the wonders of science.

LSD reaction on the human body - part 1 -

sciencenote:

what is LSD :

Lysergic acid diethylamide (LSD) is a semisynthetic product
of lysergic acid, a natural substance from the parasitic
rye fungus Claviceps purpurea. Albert Hofmann, a
natural products chemist at the Sandoz AG Pharmaceutical
Company (Basel, Switzerland) synthesized it in 1938
while searching for pharmacologically active derivatives
of lysergic acid. He accidentally discovered its dramatic
psychological effects in 1943. Though he synthesized
many lysergic acid derivatives, none had LSD’s unique
spectrum of psychological effects.

Lysergic acid diethylamide, abbreviated LSD or LSD-25, also known as lysergide (INN) and colloquially as acid, is a semisynthetic psychedelic drug of the ergoline family, well known for its psychological effects which can include altered thinking processes, closed and open eye visuals, synesthesia, an altered sense of time and spiritual experiences, as well as for its key role in 1960s counterculture. It is used mainly as an entheogen, recreational drug, and as an agent in psychedelic therapy. LSD is non-addictive, is not known to cause brain damage, and has extremely low toxicity relative to dose, although in rare cases adverse psychiatric reactions such as anxiety or delusions are possible

approachingsignificance:

Skin-Tissue Culture
Photograph by Jean Claude Revy-ISM/Phototake USA
A researcher handles a skin tissue culture. Surgeons once grafted pigskin onto burn wounds as a temporary bandage. These days they use human skin tissue taken from another part of the body or skin substitutes engineered from synthetics or other materials such as cow collagen or shark cartilage.

approachingsignificance:

Skin-Tissue Culture

Photograph by Jean Claude Revy-ISM/Phototake USA

A researcher handles a skin tissue culture. Surgeons once grafted pigskin onto burn wounds as a temporary bandage. These days they use human skin tissue taken from another part of the body or skin substitutes engineered from synthetics or other materials such as cow collagen or shark cartilage.

staceythinx:

Chirurgicale illustrée, anatomy in color. French. Archives de Doyen, 1911


  How Drug Company Money is Undermining Science
  
  When Robert Lindsay chose to become a medical researcher in the early 1970s, he did not do it for the money. His field—the effect of hormones on bone—was a backwater. It was also a perfect opportunity for a young researcher to make his mark and, he hoped, help millions of people who suffered from the bone disease osteoporosis. As the body ages, sometimes bones lose the ability to rebuild themselves fast enough to keep pace with the normal process of deterioration, and the skeleton weakens. Neither Lindsay nor anyone else understood much about why this happened, but there was reason to think that hormones might play a role. Some women develop osteoporosis shortly after menopause, when their hormone levels drop sharply, perhaps upsetting that balance between bone creation and destruction. If so, Lindsay reasoned, replacing the hormones with a pill might halt or even reverse the progress of the disease. From a tiny, underfunded clinic in Glasgow, Scotland, he set up one of the first clinical trials of estrogen replacement therapy for bone loss in postmenopausal women. Lindsay’s star was rising.
  
  His next project had big commercial implications and got the attention of the drug industry. Having moved to Helen Hayes Hospital, a rehabilitation center north of New York City, in 1984 he published work that established the minimum effective dosage of an antiosteoporosis estrogen drug called Premarin. Because the findings suggested that fighting osteoporosis was tantamount to encouraging millions of women to use the drug, it made Lindsay an important person in the eyes of the drug’s manufacturer, Wyeth-Ayerst Laboratories. Indeed, the company gave him a role as an author of its informational video Osteoporosis: A Preventable Tragedy.
  
  By the mid-1990s, when Wyeth got caught in a patent battle over Premarin, Lindsay was a staunch Wyeth ally. He came out against approval of a generic version of the drug that would have cut into sales even though the generic form would have made it easier for osteoporosis patients to receive therapy. His reasoning was that such versions might not be precisely equivalent to the brand-name drug, a fact that can be true with certain drugs but was also a position that happened to echo the company line. “All we’re asking is that we don’t approve something now and regret it” later, he told the Associated Press in 1995. Lindsay’s close relationship with Wyeth and other drug companies carried on for decades, in ways that were sometimes hidden. He started allowing Wyeth to draft research articles and began taking tens of thousands of dollars from pharmaceutical interests that stood to gain from his research.
  
  The scandal is not what Lindsay did so much as that his case is typical. In the past few years the pharmaceutical industry has come up with many ways to funnel large sums of money—enough sometimes to put a child through college—into the pockets of independent medical researchers who are doing work that bears, directly or indirectly, on the drugs these firms are making and marketing. The problem is not just with the drug companies and the researchers but with the whole system—the granting institutions, the research labs, the journals, the professional societies, and so forth. No one is providing the checks and balances necessary to avoid conflicts. Instead organizations seem to shift responsibility from one to the other, leaving gaps in enforcement that researchers and drug companies navigate with ease, and then shroud their deliberations in secrecy.
  
  “There isn’t a single sector of academic medicine, academic research or medical education in which industry relationships are not a ubiquitous factor,” says sociologist Eric Campbell, a professor of medicine at Harvard Medical School. Those relationships are not all bad. After all, without the help of the pharmaceutical industry, medical researchers would not be able to turn their ideas into new drugs. Yet at the same time, Campbell argues, some of these liaisons co-opt scientists into helping sell pharmaceuticals rather than generating new knowledge.
  
  Continue to Full Article

How Drug Company Money is Undermining Science

When Robert Lindsay chose to become a medical researcher in the early 1970s, he did not do it for the money. His field—the effect of hormones on bone—was a backwater. It was also a perfect opportunity for a young researcher to make his mark and, he hoped, help millions of people who suffered from the bone disease osteoporosis. As the body ages, sometimes bones lose the ability to rebuild themselves fast enough to keep pace with the normal process of deterioration, and the skeleton weakens. Neither Lindsay nor anyone else understood much about why this happened, but there was reason to think that hormones might play a role. Some women develop osteoporosis shortly after menopause, when their hormone levels drop sharply, perhaps upsetting that balance between bone creation and destruction. If so, Lindsay reasoned, replacing the hormones with a pill might halt or even reverse the progress of the disease. From a tiny, underfunded clinic in Glasgow, Scotland, he set up one of the first clinical trials of estrogen replacement therapy for bone loss in postmenopausal women. Lindsay’s star was rising.

His next project had big commercial implications and got the attention of the drug industry. Having moved to Helen Hayes Hospital, a rehabilitation center north of New York City, in 1984 he published work that established the minimum effective dosage of an antiosteoporosis estrogen drug called Premarin. Because the findings suggested that fighting osteoporosis was tantamount to encouraging millions of women to use the drug, it made Lindsay an important person in the eyes of the drug’s manufacturer, Wyeth-Ayerst Laboratories. Indeed, the company gave him a role as an author of its informational video Osteoporosis: A Preventable Tragedy.

By the mid-1990s, when Wyeth got caught in a patent battle over Premarin, Lindsay was a staunch Wyeth ally. He came out against approval of a generic version of the drug that would have cut into sales even though the generic form would have made it easier for osteoporosis patients to receive therapy. His reasoning was that such versions might not be precisely equivalent to the brand-name drug, a fact that can be true with certain drugs but was also a position that happened to echo the company line. “All we’re asking is that we don’t approve something now and regret it” later, he told the Associated Press in 1995. Lindsay’s close relationship with Wyeth and other drug companies carried on for decades, in ways that were sometimes hidden. He started allowing Wyeth to draft research articles and began taking tens of thousands of dollars from pharmaceutical interests that stood to gain from his research.

The scandal is not what Lindsay did so much as that his case is typical. In the past few years the pharmaceutical industry has come up with many ways to funnel large sums of money—enough sometimes to put a child through college—into the pockets of independent medical researchers who are doing work that bears, directly or indirectly, on the drugs these firms are making and marketing. The problem is not just with the drug companies and the researchers but with the whole system—the granting institutions, the research labs, the journals, the professional societies, and so forth. No one is providing the checks and balances necessary to avoid conflicts. Instead organizations seem to shift responsibility from one to the other, leaving gaps in enforcement that researchers and drug companies navigate with ease, and then shroud their deliberations in secrecy.

“There isn’t a single sector of academic medicine, academic research or medical education in which industry relationships are not a ubiquitous factor,” says sociologist Eric Campbell, a professor of medicine at Harvard Medical School. Those relationships are not all bad. After all, without the help of the pharmaceutical industry, medical researchers would not be able to turn their ideas into new drugs. Yet at the same time, Campbell argues, some of these liaisons co-opt scientists into helping sell pharmaceuticals rather than generating new knowledge.

Continue to Full Article

nbcnews:

Clown doctors bring levity to serious situations
(Photo: Srdjan Zivulovic / Reuters)
Since 2004 15 clown doctors, inspired by the U.S. Doctor ‘Patch’ Adams, visit different hospitals throughout Slovenia 2-3 times a week, using laughter to help aid the recovery of young and elderly patients suffering from serious illness or injury.
Read the complete story.

That is just too awesome.

nbcnews:

Clown doctors bring levity to serious situations

(Photo: Srdjan Zivulovic / Reuters)

Since 2004 15 clown doctors, inspired by the U.S. Doctor ‘Patch’ Adams, visit different hospitals throughout Slovenia 2-3 times a week, using laughter to help aid the recovery of young and elderly patients suffering from serious illness or injury.


That is just too awesome.